[Influencing of the serum properdin levels of patients with neoplasms by parenteral administration of zymosan].
D006402:Hematologic Diseases; D006801:Humans; D009369:Neoplasms / Q000097:blood*; D011134:Polysaccharides / Q000494:pharmacology*; D011414:Properdin; D015054:Zymosan
D011134:Polysaccharides; D011414:Properdin; D015054:Zymosan
NEOPLASMS/blood; POLYSACCHARIDES/pharmacology; PROPERDIN